Description

3-Cyclopropyl-1-(2-Fluorophenyl)-6-Methyl-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active pharmaceutical ingredients (APIs). This compound is valued for its complex heterocyclic structure, which serves as a critical building block in modern medicinal chemistry. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly in areas requiring sophisticated molecular scaffolds.

Application

• Pharmaceutical Intermediate: A key precursor in the research and development of new drug candidates, especially for targeted therapies.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• API Synthesis: Employed in the multi-step synthesis of complex final active pharmaceutical ingredients.
• Biochemical Research: Serves as a tool compound for investigating biological pathways and enzyme interactions.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for cGMP production of clinical trial materials.

Basic Information

Product Name	3-Cyclopropyl-1-(2-Fluorophenyl)-6-Methyl-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid
CAS No.	1018164-82-3
Molecular Formula	C₁₈H₁₄FN₃O₂
Molecular Weight	323.32 g/mol
Synonyms	3-Cyclopropyl-1-(2-fluorophenyl)-6-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid; 1H-Pyrazolo[3,4-b]pyridine-4-carboxylic acid, 3-cyclopropyl-1-(2-fluorophenyl)-6-methyl-; 1018164-82-3; 3-Cyclopropyl-1-(2-fluorophenyl)-6-methylpyrazolo[3,4-b]pyridine-4-carboxylic acid; 3-Cyclopropyl-1-(2-fluorophenyl)-6-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid; 3-Cyclopropyl-1-(2-fluorophenyl)-6-methylpyrazolo[3,4-b]pyridin-4-carboxylic acid
EINECS	Contact for details

Quality Control

Our 3-Cyclopropyl-1-(2-Fluorophenyl)-6-Methyl-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) with detailed specifications are available upon request to support your quality and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The product should be kept under inert conditions if long-term stability is required. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.